Novel Tyrosine Kinase Targets in Urothelial Carcinoma

Urothelial carcinoma represents one of the most prevalent types of cancer worldwide, and its incidence is expected to grow. Although the treatment of the advanced disease was based on chemotherapy for decades, the developments of different therapies, such as immune checkpoint inhibitors, antibody dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres-Jiménez, Javier, Albarrán-Fernández, Víctor, Pozas, Javier, Román-Gil, María San, Esteban-Villarrubia, Jorge, Carrato, Alfredo, Rosero, Adriana, Grande, Enrique, Alonso-Gordoa, Teresa, Molina-Cerrillo, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828553/
https://www.ncbi.nlm.nih.gov/pubmed/33451055
http://dx.doi.org/10.3390/ijms22020747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828553/
https://www.ncbi.nlm.nih.gov/pubmed/33451055
http://dx.doi.org/10.3390/ijms22020747

Ejemplares similares